CN Stock MarketDetailed Quotes
688235 BeiGene, Ltd.
- 159.55
- +0.20+0.13%
Market Closed Jan 3 15:00 CST
220.95BMarket Cap-33.87P/E (TTM)
161.99High157.97Low14.57KlotVolume160.03Open159.35Pre Close232.72MTurnover1.27%Turnover RatioLossP/E (Static)1.38BShares207.9852wk High9.11P/B18.36BFloat Cap98.5052wk Low191.22Limit Up115.06MShs Float207.98Historical High127.48Limit Down2.52%Amplitude82.00Historical Low--Dividend TTM159.77Avg Price6.10KlotAsk--Div YieldTTM100Lot Size7.09KlotBid
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
BeiGene, Ltd. Stock Forum
alphaedgeinvest...
$BEIGENE (06160.HK)$ $BeiGene (BGNE.US)$
China Galaxy: BeiGene Ltd – Initiate coverage with an Add rating, Target Price HK$169.70 - Alpha Edge Investing
$BEIGENE (06160.HK)$ $BeiGene (BGNE.US)$
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...
$MICROPORT (00853.HK)$ $WEIGAO GROUP (01066.HK)$ $CSPC PHARMA (01093.HK)$ $SINOPHARM (01099.HK)$ $CR MEDICAL (01515.HK)$ $CONSUN PHARMA (01681.HK)$ $CHUNLI MEDICAL (01858.HK)$ $UNI MEDICAL (02666.HK)$ $HENLIUS (02696.HK)$ $B-Soft Co.,Ltd. (300451.SZ)$ $Guangxi LiuYao Group (603368.SH)$ $BEIGENE (06160.HK)$
$BEIGENE (06160.HK)$ $CSPC PHARMA (01093.HK)$ $HENLIUS (02696.HK)$ $MICROPORT (00853.HK)$ $WEIGAO GROUP (01066.HK)$ $SINOPHARM (01099.HK)$ $CR MEDICAL (01515.HK)$ $CONSUN PHARMA (01681.HK)$ $CHUNLI MEDICAL (01858.HK)$ $UNI MEDICAL (02666.HK)$ $HENLIUS (02696.HK)$ $B-Soft Co.,Ltd. (300451.SZ)$ $Guangxi LiuYao Group (603368.SH)$ $BEIGENE (06160.HK)$
$BEIGENE (06160.HK)$
$BEIGENE (06160.HK)$ $BeiGene, Ltd. (688235.SH)$ $BeiGene (BGNE.US)$
Compared with $Hang Seng Index (800000.HK)$ , the better index for Hong Kong stocks this year is the red chip index (HSCCI), which has almost no private companies, mainly state-owned and central enterprises.
The SOE index may be weaker than the Hang Seng. Now the INDEX of State-owned Enterprises (HSCEI), the full na...
No comment yet